Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-11-000025
Filing Date
2011-11-14
Accepted
2011-11-14 17:01:33
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-093011.htm 10-Q 635041
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16107
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 16248
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6181
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6191
  Complete submission text file 0000318306-11-000025.txt   1957805

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT accp-20110930.xml EX-101.INS 195138
7 XBRL TAXONOMY SCHEMA accp-20110930.xsd EX-101.SCH 12379
8 XBRL TAXONOMY CALCULATION LINKBASE accp-20110930_cal.xml EX-101.CAL 38761
9 XBRL TAXONOMY DEFINITION LINKBASE accp-20110930_def.xml EX-101.DEF 17972
10 XBRL TAXONOMY LABEL LINKBASE accp-20110930_lab.xml EX-101.LAB 163612
11 XBRL TAXONOMY PRESENTATION LINKBASE accp-20110930_pre.xml EX-101.PRE 96605
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 111204012
SIC: 2834 Pharmaceutical Preparations